◀ Back to ATP5O

ATP5O — CCL2

Text-mined interactions from Literome

Teshima et al., Int Arch Allergy Immunol 2000 : Effect of Ca ( 2+ ) ATPase inhibitors on MCP-1 release from bone marrow derived mast cells and the involvement of p38 MAP kinase activation ... The effect of two Ca ( 2+ ) ATPase inhibitors, cyclopiazonic acid (CPA) and 2,5-di- ( tert-butyl ) -1,4-hydroquinone ( DTBHQ ), on the release of MCP-1 from bone marrow derived mast cells ( BMMCs ) were investigated ... These Ca ( 2+ ) ATPase inhibitors induced MCP-1 release in the absence of phorbol ester, in contrast to their induction of TNF-alpha
Onose et al., Immunol Lett 1998 : Ca2+-ATPase inhibitor induces IL-4 and MCP-1 production in RBL-2H3 cells ... The effects of a Ca2 ( + ) -ATPase inhibitor, cyclopiazonic acid (CPA), and two hydroquinone-antioxidants, 2,5-di- ( tert-butyl ) -1,4-hydroquinone ( DTBHQ ) and 2,5-di- ( tert-amyl ) -1,4-hydroquinone ( DTAHQ ) on the release of IL-4 and MCP-1 from RBL-2H3 cells were investigated